Emerging Markets

Click here to access your FREE copy.

Click here to receive your FREE copy of the white paper: Opportunities and Threats in the BRIC Pharmaceutical Markets: Assessing the Impact of Recent Pricing, Reimbursement, and Market Access Developments

Click here to receive your FREE copy of the white paper: China’s Pharmaceutical Market: The Promise and the Pitfalls.

Key Users

Global Market Research
Global Government Affairs
New Product Planning
Commercial Analysis
Epidemiology

The Ultimate Analysis of New and Growing Pharmaceutical Markets

Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis.

With these reports, clients are able to:

More accurately assess commercial opportunity for Western brands in emerging markets
Understand the physician treatment patterns and drivers of choice in key urban areas based on primary research
Gain a clear perspective from a 5-year, drug-level market forecast, which is broken out by multinational companies’ sales versus their national competitors

Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians’ practices.

Key elements of each report include:

Accurate sizing of and projections for the diagnosed and treated patient populations at national and city-specific levels
Projections for future patient populations with access to Western medicine based on trends in lifestyle, urbanization and economic status
Current treatment patterns and drivers of choice from physicians in key urban areas
Physician-defined unmet needs in diagnosing and treating the disease
Disease-specific pricing and reimbursement environment
Key drivers of overall market growth and analysis of dynamics unique to the individual major city markets

The following links provide detailed information on our primary research methodology for emerging markets we have already covered in our Emerging Markets report series.

Primary Research Methodology: China

Primary Research Methodology: India

Methodology for Generating Chinese Epidemiology Estimates

Our most recent Emerging Markets reports:

View all Emerging Markets Reports

Search Reports

Filter results:

Cancer
Cardiovascular
Central Nervous System
Infectious Disease
Immune & Inflammatory
Metabolic Disorder
Pain Management
Respiratory Disorders
Genitourinary
Gastrointestinal
Other High-Interest Diseases

Emerging Markets

Key Users

The Ultimate Analysis of New and Growing Pharmaceutical Markets

Key elements of each report include:

Our most recent Emerging Markets reports:

Search Reports

Products and Services

Round-Up